翻訳と辞書 |
Association for Ocular Pharmacology and Therapeutics : ウィキペディア英語版 | Association for Ocular Pharmacology and Therapeutics
The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics. ==History== AOPT was begun informally in the 1970s by Dr. George Chiou〔George Chiou is the founder and first president of AOPT. ''Ophthalmic Toxicology'', 2nd edition. Taylor and Francis. Philadelphia, PA.〕 as special sessions at the Federation of American Societies for Experimental Biology conferences. It grew to an official separate Symposium of Ocular Pharmacology meeting of academicians, clinicians, and pharmaceutical industry at Novi, Michigan in August 1993.〔Recent Advances in Ocular Pharmacology. Symposium proceedings. Novi, Michigan, August 8–10, 1993.J Ocul Pharmacol. 1994 Spring;10(1):1-410.〕 The participants voted to charter the organization and this was accomplished the next year with the first AOPT meeting held in New Orleans, Louisiana in January 1995. The founding board comprised Drs. George Chiou (president), David Lee (vice-president), Hitoshi Shichi (treasurer), and Herbert Kaufman (trustee). During the early FASEB years, Chiou also established the ''Journal of Ocular Pharmacology'', now the ''Journal of Ocular Pharmacology & Therapeutics''. The history of AOPT is closely related to the Association for Research in Vision and Ophthalmology (ARVO).〔GEORGE C.Y. CHIOU. ''The Birth of Association for Ocular Pharmacology and Therapeutics.'' Journal of Ocular Pharmacology and Therapeutics. Fall 1995, 11(3): 191-192. doi:10.1089/jop.1995.11.191.〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Association for Ocular Pharmacology and Therapeutics」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|